Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Heart Failure
  Free Subscription

Articles published in
N Engl J Med
    April 2024
  1. SAPP JL, Sivakumaran S, Tang ASL
    Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure. Reply.
    N Engl J Med. 2024;390:1343-1345.
    >> Share

  2. PINTEA BENTEA G, Castro Rodriguez J
    Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure.
    N Engl J Med. 2024;390:1344.
    >> Share

  3. BYUN JH, Nguyen S
    Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure.
    N Engl J Med. 2024;390:1343-1344.
    >> Share

  4. YNDIGEGN T, Lindahl B, Mars K, Alfredsson J, et al
    Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
    N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2401479.
    >> Share

  5. ROULEAU J
    Decreasing the Risk of Heart Failure in a Changing Post-Myocardial Infarction Environment.
    N Engl J Med. 2024 Apr 6. doi: 10.1056/NEJMe2402719.
    >> Share

  6. KOSIBOROD MN, Petrie MC, Borlaug BA, Butler J, et al
    Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
    N Engl J Med. 2024 Apr 6. doi: 10.1056/NEJMoa2313917.
    >> Share

    January 2024
  7. SAPP JL, Sivakumaran S, Redpath CJ, Khan H, et al
    Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure.
    N Engl J Med. 2024;390:212-220.
    >> Share

    December 2023
  8. SOHNS C, Tijssen JGP, Sommer P
    Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation. Reply.
    N Engl J Med. 2023;389:2496-2497.
    >> Share

  9. KERLEY RN, Joyce E
    Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation.
    N Engl J Med. 2023;389:2495-2496.
    >> Share

  10. BLACKWELL JN, Olshansky B, Estes NAM 3rd
    Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation.
    N Engl J Med. 2023;389:2495.
    >> Share

  11. KOSIBOROD MN, Borlaug BA, Petrie MC
    Semaglutide and Heart Failure with Preserved Ejection Fraction and Obesity. Reply.
    N Engl J Med. 2023;389:2398-2399.
    >> Share

  12. O'DOWLING R
    Semaglutide and Heart Failure with Preserved Ejection Fraction and Obesity.
    N Engl J Med. 2023;389:2398.
    >> Share

  13. WAGNER J
    Semaglutide and Heart Failure with Preserved Ejection Fraction and Obesity.
    N Engl J Med. 2023;389:2398.
    >> Share

  14. GAO Y, Gao Y, Qiu H
    Semaglutide and Heart Failure with Preserved Ejection Fraction and Obesity.
    N Engl J Med. 2023;389:2397-2398.
    >> Share

    November 2023
  15. MENTZ RJ, Hernandez AF
    Ferric Carboxymaltose in Heart Failure with Iron Deficiency. Reply.
    N Engl J Med. 2023;389:10.
    >> Share

  16. ANKER SD, Filippatos G, Anker MS
    Ferric Carboxymaltose in Heart Failure with Iron Deficiency.
    N Engl J Med. 2023;389:10.
    >> Share

  17. EISENGA MF
    Ferric Carboxymaltose in Heart Failure with Iron Deficiency.
    N Engl J Med. 2023;389:10.
    >> Share

  18. PAYAN-PERNIA S, Perez-Simon JA, Garcia-Erce JA
    Ferric Carboxymaltose in Heart Failure with Iron Deficiency.
    N Engl J Med. 2023;389:10.
    >> Share

    October 2023
  19. MACK MJ, Leon MB, Thourani VH, Pibarot P, et al
    Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years.
    N Engl J Med. 2023 Oct 24. doi: 10.1056/NEJMoa2307447.
    >> Share

  20. LEWIS EF
    Catheter Ablation for Atrial Fibrillation in Heart Failure - An Option to Defer Transplantation?
    N Engl J Med. 2023;389:1429-1430.
    >> Share

    August 2023

  21. Obesity and Heart Failure.
    N Engl J Med. 2023;389:e15.
    >> Share

  22. SOHNS C, Fox H, Marrouche NF, Crijns HJGM, et al
    Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation.
    N Engl J Med. 2023 Aug 27. doi: 10.1056/NEJMoa2306037.
    >> Share

  23. STAHLI BE, Varbella F, Linke A, Schwarz B, et al
    Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2023 Aug 27. doi: 10.1056/NEJMoa2307823.
    >> Share

  24. MARTENS P, Mullens W
    Treating Iron Deficiency in Heart Failure.
    N Engl J Med. 2023 Aug 26. doi: 10.1056/NEJMe2308305.
    >> Share

  25. MENTZ RJ, Garg J, Rockhold FW, Butler J, et al
    Ferric Carboxymaltose in Heart Failure with Iron Deficiency.
    N Engl J Med. 2023 Aug 26. doi: 10.1056/NEJMoa2304968.
    >> Share

  26. KOSIBOROD MN, Abildstrom SZ, Borlaug BA, Butler J, et al
    Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
    N Engl J Med. 2023 Aug 25. doi: 10.1056/NEJMoa2306963.
    >> Share

  27. PINTO YM
    Heart Failure with Preserved Ejection Fraction - A Metabolic Disease?
    N Engl J Med. 2023 Aug 25. doi: 10.1056/NEJMe2309294.
    >> Share

    July 2023
  28. GARCIA-PAVIA P, Aus dem Siepen F, Donal E, Lairez O, et al
    Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid.
    N Engl J Med. 2023;389:239-250.
    >> Share

    April 2023
  29. CHANG LL, DesJardin JT, Albert MA, Ezekowitz J, et al
    Dietary Sodium Restriction in Patients with Heart Failure.
    N Engl J Med. 2023;388:1621-1623.
    >> Share

    March 2023
  30. LEE DS, Ross HJ
    Trial of an Intervention to Improve Acute Heart Failure Outcomes. Reply.
    N Engl J Med. 2023;388:e46.
    >> Share

  31. PELED H, Dau NQ
    Trial of an Intervention to Improve Acute Heart Failure Outcomes.
    N Engl J Med. 2023;388:e46.
    >> Share

  32. FAN SC, Hsu NC
    Trial of an Intervention to Improve Acute Heart Failure Outcomes.
    N Engl J Med. 2023;388:e46.
    >> Share

  33. HOUSTON BA, Brittain EL, Tedford RJ
    Right Ventricular Failure.
    N Engl J Med. 2023;388:1111-1125.
    >> Share

  34. STONE GW, Abraham WT, Lindenfeld J, Kar S, et al
    Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation.
    N Engl J Med. 2023 Mar 5. doi: 10.1056/NEJMoa2300213.
    >> Share

  35. SORAJJA P, Whisenant B, Hamid N, Naik H, et al
    Transcatheter Repair for Patients with Tricuspid Regurgitation.
    N Engl J Med. 2023 Mar 4. doi: 10.1056/NEJMoa2300525.
    >> Share

    January 2023
  36. SOLOMON SD, Vaduganathan M, McMurray JJV
    Dapagliflozin in Heart Failure with Preserved Ejection Fraction. Reply.
    N Engl J Med. 2023;388:288.
    >> Share

  37. GABRIELLI D, Oliva F, Zuccala G
    Dapagliflozin in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2023;388:287-288.
    >> Share

  38. WEIR RAP
    Dapagliflozin in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2023;388:287.
    >> Share

  39. REDFORS B, Omerovic E
    Dapagliflozin in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2023;388:286-287.
    >> Share

  40. ZWECK E, Westenfeld R
    Dapagliflozin in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2023;388:286.
    >> Share

  41. GOYAL P, Horn EM
    More COACHing Needed to Optimize Care after Heart Failure Hospitalization.
    N Engl J Med. 2023;388:82-83.
    >> Share

    December 2022
  42. MULLENS W, Martens P
    Acute Decompensated Heart Failure, Volume, and Acetazolamide. Reply.
    N Engl J Med. 2022;387:2487.
    >> Share

  43. FAUCHIER L, Maisons V, Halimi JM
    Acute Decompensated Heart Failure, Volume, and Acetazolamide.
    N Engl J Med. 2022;387:2486-2487.
    >> Share

  44. KAPELIOS CJ, Drakos SG, Fang JC
    Acute Decompensated Heart Failure, Volume, and Acetazolamide.
    N Engl J Med. 2022;387:2486.
    >> Share

  45. CULIC V
    Acute Decompensated Heart Failure, Volume, and Acetazolamide.
    N Engl J Med. 2022;387:2485-2486.
    >> Share

    November 2022
  46. LEE DS, Straus SE, Farkouh ME, Austin PC, et al
    Trial of an Intervention to Improve Acute Heart Failure Outcomes.
    N Engl J Med. 2022 Nov 5. doi: 10.1056/NEJMoa2211680.
    >> Share

    October 2022
  47. PERERA D, Clayton T, O'Kane PD, Greenwood JP, et al
    Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.
    N Engl J Med. 2022;387:1351-1360.
    >> Share

  48. KIRTANE AJ
    REVIVE-ing a Weak Heart - Details Matter.
    N Engl J Med. 2022;387:1426-1427.
    >> Share

    September 2022
  49. NATHAN DM, Lachin JM, Bebu I, Burch HB, et al
    Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
    N Engl J Med. 2022;387:1075-1088.
    >> Share

    August 2022
  50. FELKER GM
    New Decongestion Strategies in an Evolving Heart Failure Landscape.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMe2209997.
    >> Share

  51. SOLOMON SD, McMurray JJV, Claggett B, de Boer RA, et al
    Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMoa2206286.
    >> Share

  52. MARGULIES KB
    DELIVERing Progress in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMe2210177.
    >> Share

  53. MULLENS W, Dauw J, Martens P, Verbrugge FH, et al
    Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMoa2203094.
    >> Share

    May 2022
  54. ANKER SD, Butler J, Packer M
    Empagliflozin in Heart Failure with a Preserved Ejection Fraction. Reply.
    N Engl J Med. 2022;386:e57.
    >> Share

  55. HEERSPINK HJL, Inker L, Greene T
    Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
    N Engl J Med. 2022;386:e57.
    >> Share

  56. AMATO J JR
    Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
    N Engl J Med. 2022;386:e57.
    >> Share

  57. TRIPOSKIADIS FK, Xanthopoulos A, Iliodromitis EK
    Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
    N Engl J Med. 2022;386:e57.
    >> Share

  58. BHATTACHARYYA D, Kar A, Dhumale S
    Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
    N Engl J Med. 2022;386:e57.
    >> Share

    November 2021
  59. PFEFFER MA, Claggett B, Lewis EF, Granger CB, et al
    Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
    N Engl J Med. 2021;385:1845-1855.
    >> Share

    September 2021
  60. KITZMAN DW, Pastva AM, Mentz RJ
    Physical Rehabilitation in Patients with Heart Failure. Reply.
    N Engl J Med. 2021;385:1340-1341.
    >> Share

  61. DUPONT J, Koppo K, Gielen E
    Physical Rehabilitation in Patients with Heart Failure.
    N Engl J Med. 2021;385:1340.
    >> Share

  62. SCHUTTLER D, Weckbach LT, Brunner S
    Physical Rehabilitation in Patients with Heart Failure.
    N Engl J Med. 2021;385:1339-1340.
    >> Share

  63. FRUSH BW
    Cool Water.
    N Engl J Med. 2021;385:1254-1255.
    >> Share

    August 2021
  64. ANKER SD, Butler J, Filippatos G, Ferreira JP, et al
    Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
    N Engl J Med. 2021 Aug 27. doi: 10.1056/NEJMoa2107038.
    >> Share

  65. DRAZNER MH
    SGLT2 Inhibition in Heart Failure with a Preserved Ejection Fraction - A Win against a Formidable Foe.
    N Engl J Med. 2021 Aug 27. doi: 10.1056/NEJMe2113008.
    >> Share

  66. PACKER M, Butler J, Zannad F, Pocock SJ, et al
    Empagliflozin and Major Renal Outcomes in Heart Failure.
    N Engl J Med. 2021 Aug 27. doi: 10.1056/NEJMc2112411.
    >> Share

  67. JOYNT MADDOX KE, Orav EJ, Zheng J, Epstein AM, et al
    Year 1 of the Bundled Payments for Care Improvement-Advanced Model.
    N Engl J Med. 2021;385:618-627.
    >> Share

    May 2021
  68. TEERLINK JR, Felker GM, McMurray JJV
    Omecamtiv Mecarbil in Systolic Heart Failure. Reply.
    N Engl J Med. 2021;384:1967-1968.
    >> Share

  69. BELLUMKONDA L
    Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2021;384:1967.
    >> Share

  70. BONAPACE S, Molon G
    Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2021;384:1967.
    >> Share

  71. KOMAMURA K
    Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2021;384:1966-1967.
    >> Share

  72. YEKU OO, Medford AJ, Fenves AZ, Uljon SN, et al
    Case 15-2021: A 76-Year-Old Woman with Nausea, Diarrhea, and Acute Kidney Failure.
    N Engl J Med. 2021;384:1943-1950.
    >> Share

  73. ANKER SD, Coats AJS
    Exercise for Frail, Elderly Patients with Acute Heart Failure - A Strong Step Forward.
    N Engl J Med. 2021 May 16. doi: 10.1056/NEJMe2106140.
    >> Share

  74. KITZMAN DW, Whellan DJ, Duncan P, Pastva AM, et al
    Physical Rehabilitation for Older Patients Hospitalized for Heart Failure.
    N Engl J Med. 2021 May 16. doi: 10.1056/NEJMoa2026141.
    >> Share

    April 2021
  75. LEE TH
    Zoom Family Meeting.
    N Engl J Med. 2021;384:1586-1587.
    >> Share

    January 2021
  76. PACKER M, Zannad F
    Empagliflozin in Heart Failure. Reply.
    N Engl J Med. 2021;384:387-388.
    >> Share

  77. KUMAR S, Sinha S
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:387.
    >> Share

  78. GERARD AO, Favre G, Esnault VLM
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:386-387.
    >> Share

  79. SHANMUGANATHAN M, Goswami RM
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:386.
    >> Share

  80. BHATTACHARYYA D, Kar A
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:385-386.
    >> Share

  81. FAUCHIER L, Fauchier G, Angoulvant D
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:385.
    >> Share

  82. LIN X, Wang S, Huang J
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:384-385.
    >> Share

  83. SWEDBERG K
    Stimulation of Contractility in Systolic Heart Failure.
    N Engl J Med. 2021;384:178-179.
    >> Share

  84. RUDDER M, Russo M, Ventetuolo CE
    Breathing for Two.
    N Engl J Med. 2021;384:61-68.
    >> Share

    November 2020
  85. BHATT DL, Szarek M, Steg PG, Cannon CP, et al
    Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
    N Engl J Med. 2020 Nov 16. doi: 10.1056/NEJMoa2030183.
    >> Share

  86. TEERLINK JR, Diaz R, Felker GM, McMurray JJV, et al
    Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2020 Nov 13. doi: 10.1056/NEJMoa2025797.
    >> Share

    October 2020
  87. ARMSTRONG PW, Anstrom KJ, O'Connor CM
    Vericiguat in Heart Failure with Reduced Ejection Fraction. Reply.
    N Engl J Med. 2020;383:1497-1498.
    >> Share

  88. RYAN JJ, Maron BA
    Vericiguat in Heart Failure with Reduced Ejection Fraction.
    N Engl J Med. 2020;383:1497.
    >> Share

  89. WEARDEN J, Hough A, Kaiser S
    Vericiguat in Heart Failure with Reduced Ejection Fraction.
    N Engl J Med. 2020;383:1496-1497.
    >> Share

    August 2020
  90. KIRCHHOF P, Camm AJ, Goette A, Brandes A, et al
    Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2019422.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016